KIROMIC BIOPHARMA INC (KRBP) Stock Price, Quote, News and Overview
NASDAQ:KRBP - Nasdaq - US4976342042 - Common Stock - Currency: USD
KRBP Quote, Performance and Key Statistics
1.45
-0.13 (-8.23%)
The current stock price of KRBP is 1.45 USD. In the past month the price decreased by -38.56%. In the past year, price decreased by -86.7%.
KRBP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.15 | 329.24B | ||
| AMGN | AMGEN INC | 14.09 | 157.29B | ||
| GILD | GILEAD SCIENCES INC | 14.09 | 135.66B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 119.21B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.37 | 59.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 40.57B | ||
| ARGX | ARGENX SE - ADR | 96.69 | 33.95B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.89 | 29.19B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.60B | ||
| NTRA | NATERA INC | N/A | 20.46B | ||
| INSM | INSMED INC | N/A | 19.52B | ||
| BIIB | BIOGEN INC | 8.06 | 18.68B |
Related stock screener links
About KRBP
Company Profile
Kiromic Biopharma, Inc. operates as a clinical-stage biotherapeutics company. The company is headquartered in Houston, Texas and currently employs 31 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The Procel, Isocel, and Deltacel product platform candidates consist of allogeneic cell therapy candidates that are in the preclinical development stage. Its Procel product candidate consists of engineered GDTs targeting PD-L1. Its Isocel product candidate consists of engineered GDTs targeting Mesothelin Isoform 2 positive tumors (Iso-Meso). Its Deltacel product candidate consists of non-engineered GDTs used to treat solid tumors. Its Allogenic Lead Exogenous Isoforms (ALEXIS)-PRO-1 trial candidate is its allogeneic GDT therapy product targeting PD-L1. Its ALEXIS-ISO-1 trial candidate is its allogenic GDT therapy product targeting an isoform of Mesothelin that is present in tumor cells, namely Isomeso.
Company Info
KIROMIC BIOPHARMA INC
7707 Fannin St., Suite 140
Houston TEXAS 77054 US
CEO: Maurizio Chiriva-Internati
Employees: 31
Phone: 18329684888.0
KIROMIC BIOPHARMA INC / KRBP FAQ
What is the stock price of KIROMIC BIOPHARMA INC today?
The current stock price of KRBP is 1.45 USD. The price decreased by -8.23% in the last trading session.
What is the ticker symbol for KIROMIC BIOPHARMA INC stock?
The exchange symbol of KIROMIC BIOPHARMA INC is KRBP and it is listed on the Nasdaq exchange.
On which exchange is KRBP stock listed?
KRBP stock is listed on the Nasdaq exchange.
What is KIROMIC BIOPHARMA INC worth?
KIROMIC BIOPHARMA INC (KRBP) has a market capitalization of 1.71M USD. This makes KRBP a Nano Cap stock.
How many employees does KIROMIC BIOPHARMA INC have?
KIROMIC BIOPHARMA INC (KRBP) currently has 31 employees.
What are the support and resistance levels for KIROMIC BIOPHARMA INC (KRBP) stock?
KIROMIC BIOPHARMA INC (KRBP) has a resistance level at 2.83. Check the full technical report for a detailed analysis of KRBP support and resistance levels.
Should I buy KIROMIC BIOPHARMA INC (KRBP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KRBP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KRBP, evaluating the profitability, health, valuation and growth aspects
- KIROMIC BIOPHARMA INC (KRBP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KIROMIC BIOPHARMA INC (KRBP) Sales and EPS estimates to see what analysts future expectations are.
- KIROMIC BIOPHARMA INC (KRBP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KIROMIC BIOPHARMA INC (KRBP) Insider and Institutional Ownership to learn about the owners and their transactions.
- KIROMIC BIOPHARMA INC (KRBP) Stock Chart to make your own analysis
- KIROMIC BIOPHARMA INC (KRBP) Latest news and press-releases to stay up to date.
Does KIROMIC BIOPHARMA INC (KRBP) stock pay dividends?
KRBP does not pay a dividend.
When does KIROMIC BIOPHARMA INC (KRBP) report earnings?
KIROMIC BIOPHARMA INC (KRBP) will report earnings on 2023-11-13, after the market close.
What is the Price/Earnings (PE) ratio of KIROMIC BIOPHARMA INC (KRBP)?
KIROMIC BIOPHARMA INC (KRBP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-47.46).
KRBP Technical Analysis
KRBP Financial Highlights
Over the last trailing twelve months KRBP reported a non-GAAP Earnings per Share(EPS) of -47.46. The EPS increased by 24.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |